Top Midday Decliners

US stocks were treading water ahead of the opening bell Thursday as investors parse initial jobless claims figures and the latest producer price index reading.

Dow Jones Industrial Average futures were up 0.2%, S&P 500 futures were off 0.05%, and Nasdaq futures were edging 0.1% lower.

Oil prices were moving higher, with front-month global benchmarks North Sea Brent crude up 1.1% and US West Texas Intermediate crude rising 1.1%.

Initial jobless claims, which track how many people filed for unemployment insurance for the first time during the past week, fell to 217,000 from 221,000 the previous week and below the 224,000 expected by forecasters, according to Bloomberg.

The producer price index, which gauges the change in input prices of raw, semi-finished, or finished goods and services, rose to 0.2% in October from 0.1% in September, and matching analyst forecasts, according to Bloomberg.

And coming out later in the morning are the Energy Information Administration's crude oil Inventories, which tracks the weekly change in the number of barrels of commercial crude oil held by US firms. Inventories are expected to fall to 1 million from 2.215 million the previous month, according to Bloomberg.

In other world markets, Japan's Nikkei was off 0.5%, Hong Kong's Hang Seng tumbled nearly 2%, and China's Shanghai Composite fell 1.7%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was rising 0.1%, while Germany's DAX 30 was climbing 1.5%, France's CAC 40 was climbing 1.3%, and Spain's IBEX 35 was climbing nearly 1%.

In equities, shares of BTC Digital jumped 43%, piling on to a 68% gain the previous session. Quantum Computing's stock surged 31%, after soaring 93% in Wednesday's trading session. Shares of Gaxos.ai advanced 55% after the company's board of directors approved Thursday the purchase of up to $1 million in Bitcoin. BTCS Inc.'s stock was up 26% after it reported Wednesday higher Q3 revenue from a year earlier. And shares of Bowman Consulting Group climbed nearly 10% following a 2% loss on Wednesday.

On the losing side, shares of Nuvectis Pharma plunged 54% after it reported data Thursday from its phase 1b trial to evaluate NXP800 in participants. Digital Brands Group shares fell 28%, eating into a 41% gain the previous session. First United Corporation (FUNC) dropped 21% after marginal loss on Wednesday. Calidi Biotherapeutics tumbled 20% after surging 60% on Wednesday. And shares of Harrow were down 18% after it reported overnight lower-than-expected Q3 total revenue.

Shares of DLocal Limited rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter revenue results.

DLocal reported quarterly earnings of 9 cents per share which missed the analyst consensus estimate of 11 cents per share. The company reported quarterly sales of $185.774 million which beat the analyst consensus estimate of $181.463 million.

DLocal shares jumped 18.3% to $10.70 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Elevai Labs Inc. gained 91.1% to $0.0472 in pre-market trading after surging 32% on Wednesday.
• SRIVARU Holding Limited rose 40% to $0.0339 in pre-market trading.
• XTI Aerospace, Inc. gained 35.7% to $0.0777 in pre-market trading after gaining 18% on Wednesday.
• Nuburu, Inc. gained 28.7% to $0.5335 in pre-market trading.
• Zoomcar Holdings, Inc. gained 26.9% to $8.25 in pre-market trading after the company reported second-quarter results.
• Quantum Computing Inc. climbed 25.8% to $3.34 in pre-market trading after jumping more than 92% on Wednesday.
• Zeta Global Holdings Corp. gained 20.5% to $21.40 in pre-market trading. Zeta Global increased its share repurchase program with $100 million buyback authorization through 2026.
• 1847 Holdings LLC E gained 17.7% to $0.5301 in pre-market trading after dipping 58% on Wednesday.
• D-Wave Quantum Inc. gained 14.6% to $2.04 in pre-market trading.

Losers

• Calidi Biotherapeutics, Inc. shares tumbled 27% to $2.47 in pre-market trading after the company announced a proposed public offering.
• Digital Brands Group, Inc. shares fell 26.5% to $0.1329 in pre-market trading after jumping over 40% on Wednesday.
• Harrow, Inc. declined 25.8% to $38.45 in pre-market trading after the company reported worse-than-expected third-quarter sales results.
• Ibotta, Inc. shares fell 22.9% to $57.75 in pre-market trading after the company reported quarterly results.
• Cyclacel Pharmaceuticals, Inc. fell 18.7% to $0.3658 in pre-market trading after gaining around 10% on Wednesday.
• Bluejay Diagnostics, Inc. dipped 18.3% to $0.0850 in pre-market trading after the company reported a 1-for-50 reverse stock split.
• Matinas BioPharma Holdings, Inc. shares dipped 15.9% to $0.5969 in pre-market trading after falling around 5% on Wednesday.
• ESS Tech, Inc. G fell 13.8% to $7.68 in pre-market trading following third-quarter results.
• Taysha Gene Therapies, Inc. fell 10.8% to $1.9700 in pre-market trading following third-quarter results.
• Super Micro Computer, Inc. fell 10.1% to $18.27 in today's pre-market trading. Super Micro Computer shares fell 6% on Wednesday after the company announced it was unable to file its quarterly report for the period ending Sept. 30 in a timely manner.

Now Read This:

• US Stocks Settle Mixed Following Inflation Data: Investor Sentiment Improves, But Fear Index Remains In ‘Greed’ Zone

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Health care stocks fell late Wednesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.6%.

The iShares Biotechnology ETF (IBB) dropped 1.3%.

In corporate news, Tevogen Bio shares surged 52%. The company said its artificial intelligence project Tevogen AI joined the Microsoft for Startups program.

Alto Neuroscience shares plunged nearly 70% after the company said late Tuesday that a phase 2b trial of ALTO-100 in people with major depressive disorder didn't meet the primary endpoint compared with a placebo.

Calidi Biotherapeutics shares sank 23% after the company said it priced a registered direct offering and simultaneous private placement.

Lumos Pharma shares jumped past 10% after the company agreed to be bought by a unit of Double Point Ventures.